Literature DB >> 10906727

Refolding a glutamine synthetase truncation mutant in vitro: identifying superior conditions using a combination of chaperonins and osmolytes.

P A Voziyan1, L Jadhav, M T Fisher.   

Abstract

A new method that uses a combination of bacterial GroE chaperonins and cellular osmolytes for in vitro protein folding is described. With this method, one can form stable chaperonin-protein folding intermediate complexes to prevent deleterious protein aggregation and, using these complexes, screen a large array of osmolyte solutions to rapidly identify the superior folding conditions. As a test substrate, we used GSDelta468, a truncation mutant of bacterial glutamine synthetase (GS) that cannot be refolded to significant yields in vitro with either chaperones or osmolytes alone. When our chaperonin/osmolyte method was employed to identify and optimize GSDelta468 refolding conditions, 67% of enzyme activity was recovered, comparable with refolding yields of wild type GS. This method can potentially be applied to the refolding of a broad spectrum of proteins. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906727     DOI: 10.1002/1520-6017(200008)89:8<1036::aid-jps8>3.0.co;2-5

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Designing a high throughput refolding array using a combination of the GroEL chaperonin and osmolytes.

Authors:  Paul A Voziyan; Mary Johnston; Angela Chao; Greg Bomhoff; Mark T Fisher
Journal:  J Struct Funct Genomics       Date:  2005

2.  The T4-encoded cochaperonin, gp31, has unique properties that explain its requirement for the folding of the T4 major capsid protein.

Authors:  Patrick J Bakkes; Bart W Faber; Harm van Heerikhuizen; Saskia M van der Vies
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

3.  Proline to the rescue.

Authors:  Mark T Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 4.  Recent applications of Kirkwood-Buff theory to biological systems.

Authors:  Veronica Pierce; Myungshim Kang; Mahalaxmi Aburi; Samantha Weerasinghe; Paul E Smith
Journal:  Cell Biochem Biophys       Date:  2007-11-28       Impact factor: 2.194

5.  Chaperonin-assisted folding of glutamine synthetase under nonpermissive conditions: off-pathway aggregation propensity does not determine the co-chaperonin requirement.

Authors:  P A Voziyan; M T Fisher
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

6.  Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions.

Authors:  Melissa Swope Willis; James K Hogan; Prakash Prabhakar; Xun Liu; Kuenhi Tsai; Yunyi Wei; Ted Fox
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

Review 7.  On the design of broad based screening assays to identify potential pharmacological chaperones of protein misfolding diseases.

Authors:  Subhashchandra Naik; Na Zhang; Phillip Gao; Mark T Fisher
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

8.  Strategies for folding of affinity tagged proteins using GroEL and osmolytes.

Authors:  Hiroo Katayama; Mitchell McGill; Andrew Kearns; Marek Brzozowski; Nicholas Degner; Bliss Harnett; Boris Kornilayev; Dubravka Matković-Calogović; Todd Holyoak; James P Calvet; Edward P Gogol; John Seed; Mark T Fisher
Journal:  J Struct Funct Genomics       Date:  2008-12-12

9.  Protein folding on biosensor tips: folding of maltodextrin glucosidase monitored by its interactions with GroEL.

Authors:  Ashutosh Pastor; Amit K Singh; Mark T Fisher; Tapan K Chaudhuri
Journal:  FEBS J       Date:  2016-08-01       Impact factor: 5.542

10.  Structural perturbation and enhancement of the chaperone-like activity of alpha-crystallin by arginine hydrochloride.

Authors:  Volety Srinivas; Bakthisaran Raman; Kunchala Sridhar Rao; Tangirala Ramakrishna; Ch Mohan Rao
Journal:  Protein Sci       Date:  2003-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.